ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery

Scientifically-designed fasting diet lowers risks for major diseases

How One Tiny Molecule Turned into One Huge Health Breakthrough

Acupuncture boosts effectiveness of standard medical care for chronic pain, depression

Research on Astaxanthin Demonstrates Significant Whole Body Benefits

Humans have three times more brown body fat

Nutrients Boost Stem Cell Function

B12 Proven Essential for Every Cell

Soy isoflavones may benefit breast cancer patients

Dietary prebiotics improve sleep, buffer impacts of stress, says study

 
Print Page
Email Article

Calling for Patients: An Open Label Study of Ampligen in Chronic Fatigue Syndrome

  [ 524 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 15, 2006


This study is currently recruiting patients. Verified by Hemispherx Biopharma September 2005
Sponsored by: Hemispherx Biopharma
Information provided by: Hemispherx Biopharma
ClinicalTrials.gov Identifier: NCT00215813 Purpose:
An Open Label Study of Ampligen in Chronic Fatigue Syndrome Condition:Chronic Fatigue Syndrome/ME
Intervention Drug: Ampligen (poly I: poly C12U)
Phase III MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Expanded Access Assignment, Safety/Efficacy Study Further study details as provided by Hemispherx Biopharma: An Open-Label Study of Poly I: Poly C12U (Ampligen®) in Patients with Severely Debilitating Chronic Fatigue Syndrome (CFS) / Myalgic Encephalomyelitis (ME). The FDA approved the study for cost recovery. Patients enrolled in the study are responsible for costs related to the therapy, e.g., drug cost, infusion cost, cost of supplies, diagnostic and other laboratory testing. Eligibility Ages Eligible for Study: 18 Years - 65 Years; Genders Eligible for Study: Both Inclusion Criteria: 1. Diagnosis of Myalgic Encephalomyelitis (ME) as defined by the 1988 CDC case definition for Chronic Fatigue Syndrome (CFS) ongoing for ³ 12 months (other clinical conditions which could present with similar symptoms must be excluded). 2. Age Range: ³ 18 years old, £ 65 years old. 3. Males or non-pregnant, non-lactating females: Females must be of non-child bearing potential (either post-menopausal for two years or surgically sterile including tubal ligation) or using an effective means of contraception (birth control pills, intrauterine device, diaphragm). Females who are less than two (2) years post-menopausal, those with tubal ligations and those using contraception must have a negative serum pregnancy test within the four (4) weeks prior to the first study medication infusion. Females of child bearing potential agree to use an effective means of contraception from four (4) weeks prior to the baseline pregnancy test until four (4) weeks after the last study medication infusion. 4. A reduced quality of life as determined by a Karnofsky Performance Score (KPS) of ³ 20 and £ 60. The KPS must be rounded in increments of ten (10). 5. Ability to provide written informed consent indicating awareness of the investigational nature of this study. 6. Documentation (during baseline or historically following onset of CFS/ME) of a negative ANA or a negative anti-ds (double-stranded) DNA, a negative Rheumatoid Factor, and an erythrocyte sedimentation rate (ESR). Documentation during baseline of a normal T4 (or other laboratory evidence that subject is euthyroid) is also required. Exclusion Criteria: Location and Contact Information Please refer to this study by ClinicalTrials.gov identifier NCT00215813 Sharon Conway 215-988-0080 sharon@hemispherx.net Study chairs or principal investigators Daniel Peterson, M.D., Principal Investigator, Sierra Internal Medicine Lucinda Bateman, M.D., Principal Investigator, Fatigue Consultation Clinic Charles W. Lapp, M.D., Principal Investigator, Hunter-Hopkins Center, P.A. More Information Study ID Numbers: AMP 511 Last Updated: December 8, 2005
Record first received: September 16, 2005
ClinicalTrials.gov Identifier: NCT00215813
Health Authority: United States: Food and Drug Administration



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Optimized Curcumin Longvida® FibroSleep™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Thyroid Health and Fibromyalgia Thyroid Health and Fibromyalgia
Curcumin - a Golden Gift of Nature with Benefits Still Untold Curcumin - a Golden Gift of Nature with Benefits Still Untold
Break Free From Fibromyalgia Break Free From Fibromyalgia
Restore Youthful Cognition and Well-Being Restore Youthful Cognition and Well-Being
Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map